Creating Accessibility to Cell and Gene Therapies

Impossible. Incurable. Inaccessible.

Our reinsurance solutions provide cost effective and comprehensive coverage for members that aligns payors and manufacturers to achieve optimal clinical and financial outcomes.

Managing Your Risks

Did you know that an estimated 350,000 patients will be treated with 30 to 60 cell and gene therapy products by 2030?

Our solutions are strategically designed to work together to drive affordability and member access to these therapies and provide risk-sharing opportunities along with outcome guarantees.

Want to learn more about how our solutions can provide financial stability?

Who We Serve

We provide specialized expertise and multifaceted solutions for the reinsurance and warranty of cell and gene therapies (CGTs). Our focus is to deliver patient access and superior clinical and financial outcomes while aligning interests across the spectrum of stakeholders.

As an independent party, we are payor-agnostic. We can partner with our clients as a stand-alone entity without disrupting existing vendor relationships.

Click below to learn how we can partner with you.

Deliver Financial Stability to Your Clients

We recognize the valuable role of the insurance brokerage community as trusted advisors to inform their clients about critical business risk issues and concerns.

OutcomeRx works collaboratively with brokers to educate their clients on the rapidly evolving CGT market and provide flexible solutions that best address the exposure for their business and their employees. We work with the wide spectrum of wholesale specialty, retail brokers and agents, benefit brokers and consultants, and reinsurance experts.


Scroll down to learn more


Approved Cell and Gene Therapies Are Increasing.

So Should Your Coverage.

Cell and gene therapies (CGTs) are moving quickly through the FDA pipeline. Whether you're a broker or TPA looking for client solutions, or an insurance carrier, captive, or MGU looking to protect your business block, it's time to add protective coverage and take back stability.

Amplify Your Protection

These potentially life-saving therapies come with multi-million-dollar price tags attached, and the costs are going nowhere but up. It's time to fill the holes in your coverage with PACCT.

  • Highly customizable first-dollar coverage
    solution for CGTs backed by A rated carriers

  • Member access to quality care at top facilities

  • Data insights that capture essential quality measures

  • Financial predictability and laser protection

  • Implement at any time

Stay ahead of new risk exposure and access coverage options that include future FDA approvals with PACCT.

Download our resources and contact us to learn more.

Reducing Uncertainty with Therapy Warranty

OutcomeRx's Cell & Gene Therapy (CGT) Warranties align healthcare stakeholders around patient access and durable clinical outcomes.

As more CGTs gain FDA approval, OutcomeRx can bridge the needs of payors and manufacturers by designing and administering therapy-specific warranties.



A therapy-specific warranty structure that mitigates financial risk and uncertainty, and improve patient access to CGTs

Flexibility for a wide array of warranty coverage options that can benefit payors, providers, or patients

Fits within existing payor and provider claims management workflows to minimize administrative burdens.

Dedicated OutcomeRx team to design, develop and manage warranty programs, including claims management


Easy to administer

Removes barriers to patient access

Differentiates your business without increasing risk

Complementary to OutcomeRx’s PACCT for payors

The Challenge

The Challenge

Value-based agreements represent alternative options to address payor concerns about cell and gene-based therapy efficacy and durability. While these options can provide a measure of risk protection, they can also be limited in coverage scope, reimbursement terms, and administratively complex for payors and providers.

The Resolution

The Resolution

OutcomeRx’s therapy-specific Therapy Warranties can mitigate payor and manufacturer challenges and help improve provider and patient access to CGTs. OutcomeRx serves as an independent third party, providing the insurance infrastructure that bridges gaps between all key stakeholders.

About Us

OutcomeRx is accelerating patient access to curative therapies. We strive to provide our clients with premier underwriting, actuarial, and clinical resources so that patients have seamless connections to top care facilities for novel cell and gene-based therapies.

Our Mission

Accelerating patient access to curative therapies through payor risk predictability and outcome-based guarantees.

Our Vision

To provide bespoke reinsurance coverage for broad patient access to personalized treatment and care management at credentialed Centers of Excellence and to align clinical and financial outcomes for both payors and manufacturers

Our Values

We believe in:

  • Patient-Centric Care – Each decision we make is centered around improving patient outcomes and reducing their financial burden.
  • Service Excellence – We provide premier service to our clients in everything we do to ensure their goals and expectations are fully met.
  • Continual Innovation – Our dedication to maintaining thought leadership and anticipating market changes drives our ever-evolving solutions and delivery to clients.
  • Trust – Our actions and decisions are motivated by building and nurturing trust in each relationship.

Our Team

Find Out More About Our Solutions

This field is for validation purposes and should be left unchanged.